{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:09:41Z","timestamp":1791234581950,"version":"4.1.0"},"reference-count":57,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Deanship of Research and Innovation at University of Hafr Al Batin","award":["0100-1446-S"],"award-info":[{"award-number":["0100-1446-S"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Carbonic anhydrase IX (CA IX) is a transmembrane metalloenzyme that is increased in tumor cells under hypoxia and plays an important role in solid tumor acidification. It is a marker of tumor hypoxia and a prognostic factor in human malignancies. Given the critical role of CA IX and their over expression in many cancer tissues, they have emerged as a promising target for developing novel anticancer therapeutics. In this study we designed a pharmacophore model based on known inhibitors to screen small compound libraries to discover potential inhibitors of CA IX. Molecular docking experiments discovered that four compounds ZINC613262012, ZINC427910039, ZINC616453231, and DB00482 exhibited a strong binding affinity towards CA IX, mimicking the interaction pattern similar to native inhibitors. Molecular dynamics simulations and an MM-PBSA analysis revealed ZINC613262012, ZINC427910039, and DB00482 as the most potential and stable inhibitors with the binding free energies \u221210.92, \u221218.77, and \u221212.29 kcal\/mol, respectively. In addition, DFT-based analyses supported their favorable electronic properties, further validating their potential as CA IX inhibitors. These three hits demonstrated a greater stability and compactness relative to the known inhibitors, suggesting these might be used CA IX inhibitors to treat tumors.<\/jats:p>","DOI":"10.3390\/ijms26178465","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T15:02:57Z","timestamp":1756825377000},"page":"8465","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Computational Discovery of Selective Carbonic Anhydrase IX (CA IX) Inhibitors via Pharmacophore Modeling and Molecular Simulations for Cancer Therapy"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3907-7091","authenticated-orcid":false,"given":"Nahlah Makki","family":"Almansour","sequence":"first","affiliation":[{"name":"Department of Biology, College of Science, University of Hafr Al Batin, Hafr Al Batin 31991, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1634\/theoncologist.9-90005-10","article-title":"The role of hypoxia-induced factors in tumor progression","volume":"9","author":"Vaupel","year":"2004","journal-title":"Oncologist"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1357-4310(00)01677-4","article-title":"Exploiting the hypoxic cancer cell: Mechanisms and therapeutic strategies","volume":"6","author":"Brown","year":"2000","journal-title":"Mol. Med. Today"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12935-020-01719-5","article-title":"The role of hypoxia in the tumor microenvironment and development of cancer stem cell: A novel approach to developing treatment","volume":"21","author":"Najafgholian","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bbabio.2010.09.003","article-title":"Oxidative phosphorylation in cancer cells","volume":"1807","author":"Solaini","year":"2011","journal-title":"Biochim. Biophys. Acta-Bioenerg."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Debnath, S.K., Debnath, M., Ghosh, A., Srivastava, R., and Omri, A. (2024). Targeting Tumor Hypoxia with Nanoparticle-Based Therapies: Challenges, Opportunities, and Clinical Implications. Pharmaceuticals, 17.","DOI":"10.3390\/ph17101389"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s10555-021-10011-5","article-title":"Understanding metabolic alterations and heterogeneity in cancer progression through validated immunodetection of key molecular components: A case of carbonic anhydrase IX","volume":"40","author":"Takacova","year":"2021","journal-title":"Cancer Metastasis Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/ijc.25491","article-title":"Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis","volume":"128","author":"Ilie","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Liao, S.-Y., Lerman, M.I., and Stanbridge, E.J. (2009). Expression of transmembrane carbonic anhydrases, CAIX and CAXII, in human development. BMC Dev. Biol., 9.","DOI":"10.1186\/1471-213X-9-22"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Yang, H., Chen, R., Zheng, X., Luo, Y., Yao, M., Ke, F., Guo, X., Liu, X., and Liu, Q. (2025). Cooperative Role of Carbonic Anhydrase IX\/XII in Driving Tumor Invasion and Metastasis: A Novel Targeted Therapeutic Strategy. Cells, 14.","DOI":"10.3390\/cells14100693"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Zhang, H., Feng, K., Li, G., Chen, W., Shao, Y., Ding, J., Zheng, M., Yuan, K., Sun, X., and Yang, P. (2025). Carbonic anhydrase IX-targeted SMDCs for cancer precision treatment. Chin. Chem. Lett., 111047.","DOI":"10.1016\/j.cclet.2025.111047"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"D\u2019Ambrosio, K., Di Fiore, A., and Langella, E. (2025). Dual targeting carbonic anhydrase inhibitors as promising therapeutic approach: A structural overview. Front. Mol. Biosci., 12.","DOI":"10.3389\/fmolb.2025.1511281"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/jclinpath-2020-207073","article-title":"Carbonic anhydrase IX: A regulator of pH and participant in carcinogenesis","volume":"74","author":"Aldera","year":"2021","journal-title":"J. Clin. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Supuran, C.T. (2021). Carbonic anhydrase inhibitors: Designing isozyme-specific inhibitors as therapeutic agents. The Carbonic Anhydrases: Current and Emerging Therapeutic Targets, Springer International Publishing.","DOI":"10.1007\/978-3-030-79511-5_10"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41416-019-0642-z","article-title":"Carbonic anhydrase IX and acid transport in cancer","volume":"122","author":"Becker","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.semcancer.2022.01.001","article-title":"Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation","volume":"86","author":"Queen","year":"2022","journal-title":"Semi. Cancer Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1152\/physrev.00018.2021","article-title":"Carbonic anhydrases in metazoan model organisms: Molecules, mechanisms, and physiology","volume":"102","author":"Aspatwar","year":"2022","journal-title":"Physiol. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"100625","DOI":"10.1016\/j.chphi.2024.100625","article-title":"Structure and non-reactive dynamics of the dimeric catalytic domain of human carbonic anhydrase IX","volume":"8","author":"Rai","year":"2024","journal-title":"Chem. Phys. Impact"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e4068","DOI":"10.7717\/peerj.4068","article-title":"An update on anticancer drug development and delivery targeting carbonic anhydrase IX","volume":"5","author":"Aspatwar","year":"2017","journal-title":"PeerJ"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_22","first-page":"100131","article-title":"Tumor associated carbonic anhydrase inhibitors: Rational approaches, design strategies, structure activity relationship and mechanistic insights","volume":"10","author":"Nerella","year":"2024","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Tatiparti, K., Rauf, M.A., Sau, S., and Iyer, A.K. (2020). Carbonic anhydrase-IX guided albumin nanoparticles for hypoxia-mediated triple-negative breast cancer cell killing and imaging of patient-derived tumor. Molecules, 25.","DOI":"10.3390\/molecules25102362"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Antal, I., Koneracka, M., Kubovcikova, M., Zavisova, V., Jurikova, A., Khmara, I., Omastova, M., Micusik, M., Barathova, M., and Jelenska, L. (2021). Targeting of carbonic anhydrase IX-positive cancer cells by glycine-coated superparamagnetic nanoparticles. Colloids Surf. B Biointerfaces, 205.","DOI":"10.1016\/j.colsurfb.2021.111893"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4155\/fmc.15.71","article-title":"Carbonic anhydrase IX inhibitors in cancer therapy: An update","volume":"7","author":"Supuran","year":"2015","journal-title":"Future Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.ejmech.2010.02.020","article-title":"Carbonic anhydrase inhibitors: Synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides","volume":"45","author":"Brzozowski","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1021\/ja809683v","article-title":"Non-zinc mediated inhibition of carbonic anhydrases: Coumarins are a new class of suicide inhibitors","volume":"131","author":"Maresca","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1016\/j.ejmech.2010.05.011","article-title":"Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1, 4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII","volume":"45","author":"Brzozowski","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00508-013-0341-3","article-title":"Acetazolamide induced severe hepatotoxicity","volume":"125","author":"Tuna","year":"2013","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejmech.2018.05.034","article-title":"Synthesis, characterization and biological evaluation of tertiary sulfonamide derivatives of pyridyl-indole based heteroaryl chalcone as potential carbonic anhydrase IX inhibitors and anticancer agents","volume":"155","author":"Peerzada","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/jhg.2013.37","article-title":"Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury","volume":"58","author":"Kaniwa","year":"2013","journal-title":"J. Hum. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/13543784.2021.2014813","article-title":"Carbonic anhydrase inhibitors: An update on experimental agents for the treatment and imaging of hypoxic tumors","volume":"30","author":"Supuran","year":"2021","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/COC.0000000000000691","article-title":"A phase 1 study of SLC-0111, a novel inhibitor of carbonic anhydrase IX, in patients with advanced solid tumors","volume":"43","author":"McDonald","year":"2020","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4155\/fmc-2022-0249","article-title":"Latest advances in specific inhibition of tumor-associated carbonic anhydrases","volume":"15","author":"Supuran","year":"2023","journal-title":"Future Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Durrant, J.D., and McCammon, J.A. (2011). Molecular dynamics simulations and drug discovery. BMC Biol., 9.","DOI":"10.1186\/1741-7007-9-71"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Salo-Ahen, O.M., Alanko, I., Bhadane, R., Bonvin, A.M., Honorato, R.V., Hossain, S., Juffer, A.H., Kabedev, A., Lahtela-Kakkonen, M., and Larsen, A.S. (2020). Molecular dynamics simulations in drug discovery and pharmaceutical development. Processes, 9.","DOI":"10.3390\/pr9010071"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.28936\/jmracpc13.2.2021.(8)","article-title":"Geometry optimization of coupling allin-Metformin using DFT\/B3LYP molecular modelling technique: Geometry optimization of coupling allin-metformin using DFT\/B3LYP molecular modelling technique","volume":"13","author":"Kadhum","year":"2021","journal-title":"Iraqi J. Mark. Res. Consum. Prot."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1080\/00397911.2024.2394833","article-title":"Spectroscopic elucidation, quantum chemical computations (FMO, HOMO\u2013LUMO, MEP, NLO), and biological activity on some novel heterocyclic compounds using 3-substituted-6, 8-dimethylchromones","volume":"54","author":"Mostafa","year":"2024","journal-title":"Synth. Commun."},{"key":"ref_39","first-page":"477","article-title":"Theoretical study of the phosphate units stability by the DFT B3LYP\/6-311G quantum method","volume":"31","author":"Boudad","year":"2023","journal-title":"J. Chem. Technol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"10484","DOI":"10.1039\/D4RA08558B","article-title":"Comprehensive assessment of 3-benzyloxyflavones as \u03b2-glucosidase inhibitors: In vitro, in vivo, kinetic, SAR and computational studies","volume":"15","author":"Naeem","year":"2025","journal-title":"RSC Adv."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1080\/10406638.2022.2039238","article-title":"Molecular structure, experimental and theoretical vibrational spectroscopy,(HOMO-LUMO, NBO) investigation,(RDG, AIM) analysis,(MEP, NLO) study and molecular docking of ethyl-2-[41] acetate","volume":"43","author":"Saidj","year":"2023","journal-title":"Polycycl. Aromat. Compd."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1080\/07391102.2024.2304137","article-title":"A virtual insight into mushroom secondary metabolites: 3D-QSAR, docking, pharmacophore-based analysis and molecular modeling to analyze their anti-breast cancer potential","volume":"43","author":"Shafiq","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4161\/cc.3.2.618","article-title":"Hypoxia inducible carbonic anhydrase IX, marker of tumour: Hypoxia, survival pathway and therapy target","volume":"3","author":"Potter","year":"2004","journal-title":"Cell Cycle"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.2174\/138161210793429832","article-title":"Carbonic anhydrase IX as an anticancer therapy target: Preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain","volume":"16","author":"Zatovicova","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"ref_45","first-page":"3","article-title":"In-silico drug design: An approach which revolutionarised the drug discovery process","volume":"1","author":"Wadood","year":"2013","journal-title":"OA Drug Des Deliv."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Marques, L., Costa, B., Pereira, M., Silva, A., Santos, J., Saldanha, L., Silva, I., Magalh\u00e3es, P., Schmidt, S., and Vale, N. (2024). Advancing precision medicine: A review of innovative In Silico approaches for drug development, clinical pharmacology and personalized healthcare. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16030332"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.2147\/JPR.S186000","article-title":"Safety of celecoxib versus traditional nonsteroidal anti-inflammatory drugs in older patients with arthritis","volume":"11","author":"Shin","year":"2018","journal-title":"J. Pain Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.7314\/APJCP.2015.16.12.4915","article-title":"Analysis of small fragment deletions of the APC gene in Chinese patients with familial adenomatous polyposis, a precancerous condition","volume":"16","author":"Chen","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1021\/acs.jmedchem.8b00770","article-title":"Discovery of 4-hydroxy-3-(3-(phenylureido) benzenesulfonamides as SLC-0111 analogues for the treatment of hypoxic tumors overexpressing carbonic anhydrase IX","volume":"61","author":"Bozdag","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_51","unstructured":"Pacheco, A.B., and Hpc, L. (2012). Introduction to AutoDock and AutoDock Tools, Louisiana State University."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"Banck","year":"2011","journal-title":"J. Cheminform."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: A new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Valiente","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/1747519821994518","article-title":"Computational studies of the thermodynamic properties, and global and reactivity descriptors of fluorescein dye derivatives in acetonitrile using density functional theory","volume":"45","author":"Juma","year":"2021","journal-title":"J. Chem. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"100400","DOI":"10.1016\/j.jics.2022.100400","article-title":"Spectroscopic (FTIR, UV-Vis, NMR) investigations, DFT predictions of global reactivity descriptors and efficient corrosion inhibitors of N-carbobenzoxy-L-ValineSuccinimidyl Ester","volume":"99","author":"Devi","year":"2022","journal-title":"J. Indian. Chem. Soc."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/17\/8465\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:36:19Z","timestamp":1760034979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/17\/8465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,30]]},"references-count":57,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["ijms26178465"],"URL":"https:\/\/doi.org\/10.3390\/ijms26178465","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,30]]}}}